Disciplined Growth Investors Inc. MN lowered its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.9% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 140,816 shares of the medical equipment provider’s stock after selling 2,766 shares during the quarter. Intuitive Surgical makes up about 3.1% of Disciplined Growth Investors Inc. MN’s holdings, making the stock its 9th biggest holding. Disciplined Growth Investors Inc. MN owned about 0.13% of Intuitive Surgical worth $147,277,000 at the end of the most recent reporting period.
Several other large investors also recently modified their holdings of ISRG. Stifel Financial Corp grew its stake in shares of Intuitive Surgical by 11.2% during the 2nd quarter. Stifel Financial Corp now owns 8,356 shares of the medical equipment provider’s stock worth $7,837,000 after purchasing an additional 841 shares during the period. Keybank National Association OH boosted its position in shares of Intuitive Surgical by 26.7% in the 2nd quarter. Keybank National Association OH now owns 1,322 shares of the medical equipment provider’s stock worth $1,237,000 after buying an additional 279 shares in the last quarter. First Trust Advisors LP boosted its position in shares of Intuitive Surgical by 61.4% in the 3rd quarter. First Trust Advisors LP now owns 51,130 shares of the medical equipment provider’s stock worth $53,476,000 after buying an additional 19,458 shares in the last quarter. Davis R M Inc. purchased a new stake in shares of Intuitive Surgical in the 3rd quarter worth about $219,000. Finally, TIAA CREF Investment Management LLC lifted its holdings in Intuitive Surgical by 9.8% in the 2nd quarter. TIAA CREF Investment Management LLC now owns 449,917 shares of the medical equipment provider’s stock valued at $420,839,000 after purchasing an additional 40,115 shares in the last quarter. Institutional investors and hedge funds own 32.80% of the company’s stock.
Shares of Intuitive Surgical, Inc. (ISRG) traded up $10.31 during midday trading on Tuesday, reaching $375.25. The company’s stock had a trading volume of 714,300 shares, compared to its average volume of 926,057. The company has a market cap of $42,050.00, a P/E ratio of 48.48, a P/E/G ratio of 5.07 and a beta of 0.48. Intuitive Surgical, Inc. has a 52 week low of $208.24 and a 52 week high of $405.05.
Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, October 19th. The medical equipment provider reported $2.77 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.99 by $0.78. The business had revenue of $806.10 million for the quarter, compared to analysts’ expectations of $753.25 million. Intuitive Surgical had a return on equity of 18.20% and a net margin of 30.16%. Intuitive Surgical’s quarterly revenue was up 18.0% on a year-over-year basis. During the same period in the previous year, the business posted $2.06 earnings per share. sell-side analysts forecast that Intuitive Surgical, Inc. will post 7.85 earnings per share for the current year.
In other news, insider Craig H. Barratt sold 15,000 shares of the company’s stock in a transaction on Tuesday, October 24th. The stock was sold at an average price of $371.18, for a total transaction of $5,567,700.00. Following the transaction, the insider now owns 7,500 shares of the company’s stock, valued at $2,783,850. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Alan J. Levy sold 2,997 shares of the company’s stock in a transaction on Tuesday, October 24th. The shares were sold at an average price of $371.35, for a total value of $1,112,935.95. The disclosure for this sale can be found here. In the last ninety days, insiders sold 55,944 shares of company stock worth $21,432,971. 2.20% of the stock is owned by insiders.
ISRG has been the topic of a number of recent research reports. Wedbush restated an “outperform” rating and issued a $353.33 target price on shares of Intuitive Surgical in a report on Monday, September 25th. Barclays reissued an “overweight” rating on shares of Intuitive Surgical in a research report on Friday, October 20th. Morgan Stanley reaffirmed an “overweight” rating on shares of Intuitive Surgical in a research report on Tuesday, September 5th. BidaskClub cut Intuitive Surgical from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, December 12th. Finally, Zacks Investment Research upgraded Intuitive Surgical from a “hold” rating to a “strong-buy” rating and set a $437.00 target price for the company in a research note on Tuesday, December 12th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and thirteen have assigned a buy rating to the company. The company has an average rating of “Buy” and an average price target of $335.32.
COPYRIGHT VIOLATION WARNING: This story was originally posted by TrueBlueTribune and is owned by of TrueBlueTribune. If you are accessing this story on another site, it was stolen and reposted in violation of international copyright & trademark legislation. The correct version of this story can be viewed at https://www.truebluetribune.com/2018/01/03/intuitive-surgical-inc-isrg-is-disciplined-growth-investors-inc-mns-9th-largest-position-2.html.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.